Trial :

COVID-19 vaccine trial

Age :

18 - 75 years

Trial length :

8 clinic visits

Info :

No overnight stays

In this trial, we are evaluating the safety and tolerability of a new investigational DNA vaccine to protect against SARS CoV-2 virus. As you are aware, this virus has caused an outbreak of an illness called coronavirus disease-19 (called “COVID‑19”) around the world. In this study, it is the first time that this particular vaccine is given to humans.

To be eligible you must:

  • Be a healthy male or healthy female who is not pregnant or who cannot bear children
  • Aged 18-75 (inclusive) 

To view the Media release for this trial, please click here.

If you meet the criteria for this study and would like more information, register below or call 1800 727 874.

Apply Now